Labshake search
Citations for Tocris :
401 - 450 of 693 citations for 8 Fluoro quinazoline 2 4 diamine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 50 D-2-amino-5-phosphonopentanoic acid (D-APV) (Tocris), and 10 gabazine (Sigma) ...
-
bioRxiv - Neuroscience 2021Quote: ... coiled-coil containing protein kinase (ROCK1/2) Y27632 (Tocris, Inc.) at 10 µM in PBS for 1-2 hr ...
-
bioRxiv - Neuroscience 2020Quote: ... and D(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) was prepared as 50 mM stocks dissolved in 30% 1 M NaOH ...
-
bioRxiv - Neuroscience 2020Quote: ... DL-2-Amino-5-phosphonopentanoic acid (APV, 50 μM, Tocris) was added to the ACSF to avoid the unintended N-methyl-D-aspartate receptor (NMDAR ...
-
bioRxiv - Neuroscience 2019Quote: ... 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris). All these compounds were applied in the recording chamber for at least 10 minutes before continuing measurements ...
-
bioRxiv - Neuroscience 2022Quote: ... and ascorbic acid (100 µL, 2 mM, Tocris Bioscience, 4055). Synaptojuice B medium was filtered through a 0.22-µm filter ...
-
bioRxiv - Neuroscience 2022Quote: ... CU-T12-9 (TLR1/2 agonist; 2.5ug/dose; Tocris; 5414), CU-CPT22 (TLR antagonist ...
-
bioRxiv - Neuroscience 2020Quote: ... GABA (10 μM, Tocris, #A5835-25G, CAS: 56-12-2), bafilomycin (4 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... and d-2-amino-5-phosphonopentanoic acid (D-AP5) (Tocris). Drugs were prepared as concentrated stock solutions and were diluted in ACSF on the day of the experiment.
-
bioRxiv - Cell Biology 2020Quote: ... Torin 1 (Tocris, 4247, 250 nM in DMSO, 2 hrs), Bortezomib (LC Labs B-1408 ...
-
bioRxiv - Developmental Biology 2022Quote: ... and GM6001 (Illomastat; CAS: 142880-36-2; Tocris, Bristol, UK) were used ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 μM apilimod dimesylate (Tocris, ref. #7283, batch 1A/257560), 50 μM camostat mesylate (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... 2 μl 20% Pluronic F-127 in DMSO (Tocris Biosciences), and 1 μl 0.5% Kolliphor EL (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2023Quote: ... Step 2: synaptic blockers (50µm DL-AP-5 (Tocris #0105), 40µm L-AP4 (Tocris #0103) ...
-
bioRxiv - Biophysics 2023Quote: Stocks of the kinase inhibitors MLi-2 (10 mM; Tocris) and GZD-824 (10 mM ...
-
bioRxiv - Biophysics 2024Quote: ... followed by supplementation with 2 µM IWP2 (Tocris, Bristol, UK) and 10 µM SB431542 for another 24 h ...
-
bioRxiv - Cell Biology 2023Quote: ... Cells were pre-treated with MLi-2 (5756/10, Tocris) at 100 nM for 2 hours and all subsequent treatments were performed in the presence of MLi-2 ...
-
bioRxiv - Neuroscience 2023Quote: ... 20 L-AP4 (Alomone Labs) and 2-5 ACET (Tocris) (Park et al. ...
-
bioRxiv - Physiology 2024Quote: ... injected with 2 mg/kg acylated rat ghrelin (1465, Tocris) solubilized in PBS using an injection volume of 2 mL/kg body weight ...
-
bioRxiv - Cell Biology 2024Quote: ... EIPA (1154-25-2) was obtained from Tocris (Bristol, UK); a protease inhibitor cocktail (04,693,159,001 ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2021Quote: ... 4-methoxy-7-nitroindoline-caged L-glutamate (MNI- caged-glutamate, 2.5 mM, Tocris Bioscience) was added to the bath solution ...
-
bioRxiv - Cell Biology 2022Quote: At day 0 cells were treated with 5 nM 4-Hydroxytamoxifen (+HOT) (Tocris, 3412) or with vehicle (-HOT ...
-
bioRxiv - Neuroscience 2020Quote: ... containing 100µM of 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI glutamate, Tocris Bioscience).
-
bioRxiv - Immunology 2019Quote: ... inhibitor of β1 integrin very late antigen (VLA-4) (Bio1211, 10 μM, Tocris bioscicence), inhibitor of macrophage-1 (MAC-1 ...
-
bioRxiv - Neuroscience 2020Quote: ... or 4-methoxy-7-nitroindolinyl (MNI)-caged L-glutamate (MNI-glutamate; 2.5 mM; Tocris), or 4-methoxy-7-nitroindolinyl (MNI)-caged L-glutamate trifluoroacetate (MNI-glutamate•TFA ...
-
bioRxiv - Bioengineering 2022Quote: ... the EBs were transferred to DMEM high glucose media with XAV (4□uM, TOCRIS) and then transferred to maturation media [DMEM containing low glucose (2□g/L ...
-
bioRxiv - Cell Biology 2023Quote: ... the EBs were transferred to DMEM high glucose media with XAV (4 uM, TOCRIS) and then transferred to maturation media (DMEM containing low glucose (2 g/L ...
-
bioRxiv - Neuroscience 2024Quote: 4-methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate) was purchased from Tocris Bioscience (1490) ...
-
bioRxiv - Biochemistry 2023Quote: ... 2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN) CAS number:1428-67-7 (Tocris, Madrid, Spain) and collagenase (Sigma-Aldrich ...
-
bioRxiv - Developmental Biology 2021Quote: ... the TGF-beta/Activin/Nodal inhibitor SB-431542 (2 μM, Tocris), CHIR99021 (1 μM) ...
-
bioRxiv - Neuroscience 2021Quote: ... leptin (twice/day for 2 days at 0.25 mg/kg, Tocris), AM251 (3 mg/kg ...
-
bioRxiv - Genomics 2020Quote: ... 2 μM of the Wnt inhibitor Wnt-C59 (5148, Tocris Bioscience), diluted in Cardiomyocyte Differentiation Media ...
-
bioRxiv - Cell Biology 2020Quote: ... MT polymerization was inhibited with 2 μM Nocodazole (Noc; Tocris; 1228). Ciliobrevin (Ciliobr ...
-
bioRxiv - Systems Biology 2021Quote: ... D-2-hydroxyglutarate (D2-HG, 0 to 1.0 mmol/L; Tocris Bioscience ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-Isopropoxy-9-xanthone-2-carboxylic acid (AH6809, 10 µM, Tocris); N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251 ...
-
bioRxiv - Biochemistry 2022Quote: ... and 10 μM AR-C 118925XX (216657-60-2, TOCRIS Bioscience) applied 10 min prior to the addition of ATP and UTP.
-
bioRxiv - Neuroscience 2019Quote: ... 2 μM SB431542 reagent (Tocris Bioscience; Bristol, UK; Cat. No. 1614), 200 ng/ml Noggin (PeproTech ...
-
bioRxiv - Neuroscience 2021Quote: ... and 40 µM D(−)-2-amino-5-phosphonovaleric acid (APV; Tocris) and 50 nM of rat CGRP or vehicle ...
-
bioRxiv - Neuroscience 2021Quote: ... DL-2-Amino-5-phosphonopentanoic acid (DL-AP5, 40 µM, Tocris), bicuculline methiodide (Bic ...
-
bioRxiv - Immunology 2020Quote: ... USA) and ZQ16 (2-(hexylthio)pyrimidine-4,6-diol) was from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2020Quote: ... and 2 μM SB431542 (Tocris Bioscience; Bristol, UK; Cat. No. 1614). The culture medium was changed every other day for 6 days and the resulting NPCs were then differentiated into motor neuron progenitor cells (MNPCs) ...
-
bioRxiv - Genomics 2022Quote: ... and 100μM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) overnight to reduce endogenous neuronal activity prior to stimulation ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 mM D-AP5 (D-2-amino-5-phosphonovalerate, Tocris) to block AMPA and NMDA receptors ...
-
bioRxiv - Neuroscience 2022Quote: ... Each well contained 2 ml of 40 μM AP4 (0101; Tocris) in sterile Ames’ medium and the cathode ...
-
bioRxiv - Cancer Biology 2022Quote: ... the TGF-beta/Activin/Nodal inhibitor SB-431542 (2 μM, Tocris), CHIR99021 (1 μM ...
-
bioRxiv - Neuroscience 2022Quote: ... D,L-2-amino-5-phosphonovaleric acid (AP5, TOCRIS bioscience #0105), and BI2536 (Selleckchem #S1109) ...
-
bioRxiv - Neuroscience 2023Quote: ... cultures were treated with 1-2 μM CHIR 98014 (Tocris #6695) as described in (44 ...